Medexus Pharmaceuticals, Inc. (MDP.TO)
2.81
-0.03
(-1.06%)
CAD |
TSX |
Feb 11, 16:00
Medexus Pharmaceuticals EPS Diluted (Quarterly) : -0.0134 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cannara Biotech, Inc. | 0.0108 |
| NexgenRx, Inc. | 0.0078 |
| Aurora Spine Corp. | -0.0025 |
| Cronos Group, Inc. | 0.0929 |
| NeuPath Health, Inc. | -0.0027 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.4338M |
| Revenue (Quarterly) | 34.07M |
| Total Expenses (Quarterly) | 34.51M |
| Enterprise Value | 107.36M |
| Gross Profit Margin (Quarterly) | 54.31% |
| Profit Margin (Quarterly) | -1.27% |
| Earnings Yield | 0.77% |
| Operating Earnings Yield | 8.73% |
| Normalized Earnings Yield | 0.9786 |